7bcea1525f3f30f32ae24b37101d352f

HEMOSIL ACUSTAR ANTI-CARDIOLIPIN IGM CONTROLS

WERFEN COLOMBIA SAS·Colombia INVIMA·Expires September 16, 2031

Device classification

Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: 7bcea1525f3f30f32ae24b37101d352f
Expire date: September 16, 2031

Authorized company / Fabricante

Name (Spanish): WERFEN COLOMBIA SAS
Name (English): THROW COLOMBIA SAS

About this record

Access comprehensive regulatory information for HEMOSIL ACUSTAR ANTI-CARDIOLIPIN IGM CONTROLS (HEMOSIL ACUSTAR ANTI-CARDIOLIPIN IGM CONTROLS) in the Colombia medical device market through Pure Global AI's free database. This medical device is registered under INVIMA analysis ID 7bcea1525f3f30f32ae24b37101d352f and manufactured by WERFEN COLOMBIA SAS. The device was registered on September 16, 2031.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.